CAAS CAPITAL MANAGEMENT
CaaS Capital Management is investing across all regions, industries, and capital structures. CaaS feels strongly in providing liquidity — Capital as a Service — to our partners and pursues this objective with great vigor and energy. CaaS uses a unique combination of fundamental and quantitative inputs when making investment decisions.
CAAS CAPITAL MANAGEMENT
Industry:
Financial Services
Founded:
2019-01-01
Status:
Active
Contact:
212-518-8501
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Accial Capital
Accial Capital is an impact-focused, tech-enabled investor in small business and consumer loan portfolios in emerging markets
Prysm Capital
Prysm Capital is a flexible source of growth capital to companies across the technology, consumer and healthcare sectors.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-16 | 2seventy bio | CaaS Capital Management investment in Post-IPO Equity - 2seventy bio | 170 M USD |
| 2021-11-29 | HotSpot Therapeutics | CaaS Capital Management investment in Series C - HotSpot Therapeutics | 100 M USD |
| 2021-08-02 | T-knife | CaaS Capital Management investment in Series B - T-knife | 110 M USD |
| 2021-07-27 | Artios Pharma | CaaS Capital Management investment in Series C - Artios Pharma | 110 M GBP |
| 2021-07-14 | Turnstone Biologics | CaaS Capital Management investment in Series D - Turnstone Biologics | 80 M USD |
| 2021-06-15 | Umoja Biopharma | CaaS Capital Management investment in Series B - Umoja Biopharma | 210 M USD |
| 2021-04-13 | Arcellx | CaaS Capital Management investment in Series C - Arcellx | N/A |
| 2021-03-16 | StrideBio | CaaS Capital Management investment in Series B - StrideBio | 81.5 M USD |
| 2021-03-16 | Rapid Micro Biosystems | CaaS Capital Management investment in Private Equity Round - Rapid Micro Biosystems | 81 M USD |
| 2021-03-04 | Amunix | CaaS Capital Management investment in Series B - Amunix | 117 M USD |